| scholarly article | Q13442814 |
| P50 | author | Kwok Wai Lo | Q59247702 |
| Chi Man Tsang | Q90584750 | ||
| P2093 | author name string | Sai Wah Tsao | |
| P2860 | cites work | An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival | Q24649032 |
| From Conventional to Next Generation Sequencing of Epstein-Barr Virus Genomes | Q26765442 | ||
| Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients | Q26823898 | ||
| Epstein-Barr Virus: Diseases Linked to Infection and Transformation | Q28074586 | ||
| Epstein-Barr virus latent genes | Q28082701 | ||
| Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma | Q28191706 | ||
| Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies | Q39666008 | ||
| Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta | Q39716669 | ||
| A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. | Q39736828 | ||
| Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling | Q28588278 | ||
| A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci | Q28943422 | ||
| Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches | Q29036707 | ||
| Epstein-Barr virus: 40 years on | Q29617969 | ||
| TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma | Q30491128 | ||
| Epstein-Barr virus particles induce centrosome amplification and chromosomal instability | Q30838642 | ||
| Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma | Q33254109 | ||
| Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells | Q33360874 | ||
| Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies | Q33373662 | ||
| Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma | Q33598586 | ||
| Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. | Q33650107 | ||
| Epstein-Barr Virus Interferes with the Amplification of IFNα Secretion by Activating Suppressor of Cytokine Signaling 3 in Primary Human Monocytes | Q33650938 | ||
| Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells | Q33760239 | ||
| The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. | Q33782739 | ||
| Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells | Q33929593 | ||
| VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA | Q33971399 | ||
| Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation | Q34029669 | ||
| The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases | Q34099074 | ||
| Histology of the human nasopharyngeal mucosa | Q34105490 | ||
| Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma. | Q34200710 | ||
| Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19. | Q34237606 | ||
| Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes | Q34261921 | ||
| Loss of the tumor suppressor PML in human cancers of multiple histologic origins | Q34299352 | ||
| Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma | Q34483687 | ||
| High resolution allelotype of microdissected primary nasopharyngeal carcinoma. | Q34509844 | ||
| High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma | Q34515210 | ||
| CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma. | Q34533871 | ||
| Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations | Q34549536 | ||
| Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells | Q34598541 | ||
| Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells | Q34712473 | ||
| The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo | Q34973323 | ||
| The significance of LMP1 expression in nasopharyngeal carcinoma | Q35008886 | ||
| Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cells | Q35020438 | ||
| Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells | Q35119824 | ||
| NF-kappaB inhibits gammaherpesvirus lytic replication | Q35155154 | ||
| Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. | Q39749474 | ||
| Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity | Q39767918 | ||
| The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. | Q39806231 | ||
| Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma | Q39865449 | ||
| Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells | Q39929408 | ||
| Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection | Q40148095 | ||
| Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling | Q40192981 | ||
| Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma | Q40372899 | ||
| Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. | Q40373897 | ||
| Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity. | Q40435357 | ||
| Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells | Q40577418 | ||
| Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1. | Q40641449 | ||
| Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus | Q40934947 | ||
| EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop | Q41122951 | ||
| Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo | Q41153139 | ||
| Hypermethylation of the p16 gene in nasopharyngeal carcinoma | Q41191384 | ||
| Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. | Q41549956 | ||
| Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers. | Q41868979 | ||
| Regulation of APC/CCdc20 activity by RASSF1A-APC/CCdc20 circuitry | Q41980393 | ||
| Sequence-based typing of HLA-A gene in 930 patients with nasopharyngeal carcinoma in Hunan province, southern China | Q42144225 | ||
| Etiological factors of nasopharyngeal carcinoma | Q42231417 | ||
| Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas | Q42262852 | ||
| Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes | Q42490090 | ||
| The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation | Q43610021 | ||
| Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma | Q43860639 | ||
| Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese | Q44192526 | ||
| PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival | Q45226982 | ||
| Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas | Q45424270 | ||
| Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential | Q45608351 | ||
| Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein | Q45734610 | ||
| Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state | Q45743571 | ||
| Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. | Q45756231 | ||
| Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients | Q45822159 | ||
| Epidemiology of nasopharyngeal carcinoma. | Q45948135 | ||
| Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells. | Q46170131 | ||
| Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells | Q47978435 | ||
| PIK3CA mutations in nasopharyngeal carcinoma. | Q53355100 | ||
| Epstein-Barr virus and nasopharyngeal carcinoma | Q56947843 | ||
| p16 gene alterations in nasopharyngeal carcinoma | Q72220049 | ||
| High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese | Q73083791 | ||
| Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis | Q77340409 | ||
| Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation | Q77995454 | ||
| Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma | Q84493563 | ||
| Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma | Q38480025 | ||
| Epstein-Barr Virus Strain Variation | Q38596335 | ||
| Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus | Q38596356 | ||
| EBNA1. | Q38597231 | ||
| The Latent Membrane Protein 1 (LMP1). | Q38597238 | ||
| Epstein-Barr Virus Lytic Cycle Reactivation | Q38597247 | ||
| Immune Evasion by Epstein-Barr Virus | Q38597254 | ||
| Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. | Q38610363 | ||
| Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells | Q38928572 | ||
| Epstein-Barr virus: more than 50 years old and still providing surprises. | Q38968588 | ||
| The genomic landscape of nasopharyngeal carcinoma | Q38982367 | ||
| Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells | Q39112082 | ||
| Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. | Q39123741 | ||
| Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation | Q39148562 | ||
| Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma | Q39162375 | ||
| Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production | Q39277512 | ||
| Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma | Q39455578 | ||
| Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma. | Q39456193 | ||
| The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress | Q39577788 | ||
| Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells | Q39578660 | ||
| EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. | Q39614564 | ||
| Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma | Q39646759 | ||
| Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines | Q35363169 | ||
| Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin | Q35505126 | ||
| EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival | Q35662292 | ||
| Focus on nasopharyngeal carcinoma | Q35773862 | ||
| Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors | Q35812949 | ||
| The role of miRNAs and EBV BARTs in NPC. | Q35924359 | ||
| The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. | Q35924384 | ||
| Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma. | Q35928927 | ||
| Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells | Q36055637 | ||
| Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model | Q36099024 | ||
| An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model | Q36171933 | ||
| Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma | Q36211300 | ||
| EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma | Q36414449 | ||
| The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove | Q36433849 | ||
| A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry | Q36463672 | ||
| Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells | Q36483613 | ||
| Epstein-Barr virus-induced epigenetic alterations following transient infection | Q36625981 | ||
| Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells | Q36734903 | ||
| Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells | Q36845616 | ||
| NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. | Q37073277 | ||
| The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. | Q37114836 | ||
| New insights into the role of PML in tumour suppression | Q37173760 | ||
| Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. | Q37301260 | ||
| ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation | Q37314790 | ||
| Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma. | Q37323204 | ||
| Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers. | Q37376994 | ||
| Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis | Q37972526 | ||
| Host-tumor interactions in nasopharyngeal carcinomas | Q37976234 | ||
| The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). | Q37976235 | ||
| Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma | Q37982181 | ||
| Epstein-Barr virus infection as an epigenetic driver of tumorigenesis | Q38023841 | ||
| The role of Epstein-Barr virus in epithelial malignancies | Q38253914 | ||
| Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma | Q38273731 | ||
| Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies | Q38294587 | ||
| Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. | Q38307191 | ||
| P433 | issue | 1732 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P577 | publication date | 2017-10-01 | |
| P1433 | published in | Philosophical Transactions of the Royal Society B | Q2153239 |
| P1476 | title | Epstein-Barr virus infection and nasopharyngeal carcinoma | |
| P478 | volume | 372 |
| Q57093338 | Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells |
| Q92704623 | Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy |
| Q104473885 | Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma |
| Q47547574 | CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions |
| Q92155923 | Cancer-Associated Fibroblasts in Undifferentiated Nasopharyngeal Carcinoma: A Putative Role for the EBV-Encoded Oncoprotein, LMP1 |
| Q90208019 | Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population-based case-control study |
| Q97570260 | Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma |
| Q97423382 | Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p |
| Q92998898 | EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells |
| Q92619317 | Early Pattern of Epstein-Barr Virus Infection in Gastric Epithelial Cells by "Cell-in-cell" |
| Q92889962 | Effects of KIF2A on the prognosis of nasopharyngeal carcinoma and nasopharyngeal carcinoma cells |
| Q90481228 | Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans |
| Q90012597 | Epstein barr virus encodes miRNAs to assist host immune escape |
| Q45324762 | Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle |
| Q90433916 | Epstein-Barr Virus Infection of Oral Squamous Cells |
| Q59356534 | Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas |
| Q59355883 | Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation |
| Q58599820 | Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma |
| Q93185464 | F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model |
| Q56990996 | Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer |
| Q99563092 | HNSCC: Tumour Antigens and Their Targeting by Immunotherapy |
| Q90247420 | High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma |
| Q40046680 | Human oncogenic viruses: nature and discovery |
| Q64911477 | Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma. |
| Q90087487 | Implication of viral microRNAs in the genesis and diagnosis of Epstein-Barr virus-associated tumors |
| Q90122463 | Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States |
| Q55313422 | Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma. |
| Q92758101 | LMP1 Up-regulates Calreticulin to Induce Epithelial-mesenchymal Transition via TGF-β/Smad3/NRP1 Pathway in Nasopharyngeal Carcinoma Cells |
| Q98290394 | LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance |
| Q89623336 | Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies |
| Q59351223 | Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma |
| Q52347943 | New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma. |
| Q90255568 | Prevalence of Epstein-Barr virus, human papillomavirus, cytomegalovirus and herpes simplex virus type 1 in patients with diabetes mellitus type 2 in south-eastern Poland |
| Q90470003 | Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature |
| Q90479777 | Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases |
| Q99634411 | Roles for MDC1 in cancer development and treatment |
| Q89559080 | Seroprevalence of Epstein-Barr virus among children and adults in Tehran, Iran |
| Q96304633 | Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma |
| Q92860015 | The Global Landscape of EBV-Associated Tumors |
| Q54254993 | The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma. |
| Q90640852 | Toll-like receptor 3 (TLR3) functions as a pivotal target in latent membrane protein 1 (LMP1)-mediated nasopharyngeal carcinoma cell proliferation |
| Q91468424 | mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma |
Search more.